Title: International Conference on TRIPS-CBD Linkage: Issues and Way Forward
Date: 7-8 June 2018
Venue: Room IX, Palais des Nations, Geneva
Organizers: The South Centre, Centre for WTO Studies and the Indian Institute of Foreign Trade, co-sponsored by thePermanent Missions of Brazil, India, Indonesia and South Africa to the WTO
Acceso a medicamentos: experiencias con licencias obligatorias y uso gubernamental – el caso de la Hepatitis C
Por Dr. Carlos M. Correa y Dr. Germán Velásquez
El acceso a medicamentos está fuertemente condicionado por su precio y por los mecanismos de financiamiento que pueden aplicarse en cada país. […] Un factor determinante en la fijación del precio de los medicamentos es el grado de competencia existente en una particular clase terapéutica, la que a su vez es influenciada por la existencia o no de derechos de propiedad intelectual, como patentes de invención.
The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.
The IP Negotiations Monitor summarizes the latest developments in multilateral and regional fora where intellectual property negotiations are taking place, and informs on upcoming meetings and events.
This update provides a snapshot of the activities of the Development, Innovation and Intellectual Property Programme during the month of December 2017.
South Centre Statement at the 12th Session of the WIPO Advisory Committee on Enforcement (ACE)
In line with the mandate of the WIPO Development Agenda, WIPO must approach intellectual property enforcement in the context of broader societal interests and especially development-oriented concerns, in accordance with Article 7 of the TRIPS Agreement.
Industrialization, inequality and sustainability: What kind of industry policy do we need?
The 2030 Agenda includes as Sustainable Development Goal 9 (SDG 9) the commitment to “build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation”. The entry of this goal into the 2030 Agenda is an achievement for developing countries who have a very diverse situation in terms of population sizes, per capita incomes, economic sizes and structures, political systems, cultures but share the common feature of an underdeveloped industrial sector.Therefore, in order to implement SDG 9 pro-active industry policies are needed that take into account aspects of inequality and sustainability.
Intellectual Property in the Trans-Pacific Partnership: Increasing the Barriers for the Access to Affordable Medicines (revised)
Most free trade agreements (FTAs) signed by the United States, the European Union and the members of the European Free Trade Association (EFTA) in the last 15 years contain chapters on intellectual property rights with provisions applicable to pharmaceuticals. Such provisions considerably expand the rights recognized to pharmaceutical companies under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) established in the context of the World Trade Organization (WTO). (more…)